Preventing varicella: Recommendations for routine two-dose varicella immunization in children

Paediatrics and Child Health

Volumn 16, Issue 7, 2011, Pages

  Salvadori, Marina I ^b   Bortolussi, Robert ^a   Finlay, Jane ^b   Martin, Susanna ^c   McDonald, Jane C ^d   Onyett, Heather ^e   Robinson, Joan L ^b  

^a IWK HEALTH CENTRE   (Canada)

^b Royal University Hospital ^*

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Canada; Canadian paediatric society vaccine recommendations; Children; Vaccine schedule; Varicella vaccine

Indexed keywords

IMMUNOGLOBULIN G; VARICELLA ZOSTER VACCINE;

CANADA; CHICKENPOX; CHILD; CHILD HOSPITALIZATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; GROUPS BY AGE; HUMAN; IMMUNE RESPONSE; IMMUNITY; ONSET AGE; PRENATAL DRUG EXPOSURE; PREVENTIVE HEALTH SERVICE; RECOMMENDED DRUG DOSE; REVIEW; TREATMENT OUTCOME; VACCINATION; VACCINE FAILURE; VARICELLA ZOSTER VIRUS;

EID: 80053946731     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/16.7.415     Document Type: Review

References (20)

1. National Advisory Committee on Immunization (NACI). Varicella Vaccination Two-Dose Recommendations. CCDR 2010;36:ACS-8. 〈www.phac-aspc.gc.ca/ publicat/ccdr-rmtc/10vol36/acs-8/index-eng.php〉 (Accessed on June 8, 2011).
2. American Academy of Pediatrics, Committee on Infectious Diseases. Prevention of varicella: Recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 2007;120:221-31. 〈http://aappolicy.aappublications. org/cgi/reprint/pediatrics;120/1/221.pdf〉 (Accessed on June 8, 2011).
3. Langley J; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Prevention of varicella in children and adolescents. Paediatr Child Health 2005;10(7):409-12.
4. Final report of outcomes from the National Consensus Conference for Vaccine-Preventable Diseases in Canada. Quebec City,June 12 to 14, 2005. Can Commun Dis Rep 2008;34 Suppl 2:1-56. 〈http://www.phac-aspc.gc.ca/publicat/ ccdr-rmtc/08vol34/34s2/34s2-03-eng.php#setting〉(Accessed on June 8, 2011).
5. Tan B, Bettinger J, Scheifele D, et al. The effect of provincially-funded varicella immunization programs on varicella-related hospitalizations in IMPACT centres, 1999-2007. Oral presentation (Abstract 121) at the 86th Annual Conference of the Canadian Paediatric Society, Ottawa, June 26, 2009.
6. Kwong JC, Tanuseputro P, Zagorski B, Moineddin R, Chan KJ. Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program? Vaccine 2008;26(47):6006-12.
7. Li S, Chan IS, Matthews H, et al. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr Infect Dis J 2002;21(4):337-42. (Pubitemid 34326873)
8. Chaves SS, Gargiullo P, Zhang JX, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 2007;356(11):1121-9. (Pubitemid 46425596)
9. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287(5):606-11. (Pubitemid 34252012)
10. Marin M, Watson TL, Chaves SS, et al. Varicella among adults: Data from an active surveillance project, 1995-2005. J Infect Dis 2008;197 (Suppl 2):S94-100.
11. Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR04):1-40. 〈www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm〉(Accessed on June 8, 2011).
12. Güris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites - United States, 1995-2005. J Infect Dis 2008;197 (Suppl 2):S71-5. (Pubitemid 351590150)
13. Lee BR, Feaver SL, Miller CA, Hedberg CW, Ehresmann KR. An elementary school outbreak of varicella attributed to vaccine failure: Policy implications. J Infect Dis 2004;190(3):477-83. (Pubitemid 38982083)
14. Miron D, Lavi I, Kitov R, Hendler A. Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr Infect Dis J 2005;24(3):233-6. (Pubitemid 40365857)
15. Weinmann S, Chun C, Mullooly JP, et al. Laboratory diagnosis and characteristics of breakthrough varicella in children. J Infect Dis 2008;197 (Suppl 2):S132-8. (Pubitemid 351590160)
16. Adler AL, Casper C, Boeckh M, Heath J, Zerr DM. An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients. Infect Control Hosp Epidemiol 2008;29(9):866-70.
17. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002;347(24):1909-15. (Pubitemid 35429920)
18. Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 2004;113(3 Pt 1):455-9. (Pubitemid 38280783)
19. Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: A 10-year review. J Infect Dis 2008;197(Suppl 2):S165-9. (Pubitemid 351590166)
20. Canadian Task Force on Preventive Health Care. 〈www. canadiantaskforce.ca/recommendations/2003-04-eng.html〉 (Accessed on June 8, 2011).